BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Anthera Pharmaceuticals, Inc. 

25801 Industrial Blvd
Suite B
Hayward  California  94545  U.S.A.
Phone: 510-856–5600 Fax: 510-856–5597


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Anthera Pharmaceuticals, Inc. (ANTH) Announces Completion Of Public Offering Of Common Stock 3/24/2015 6:50:52 AM
Anthera Pharmaceuticals, Inc. (ANTH) Announces Pricing Of Public Offering Of Common Stock 3/18/2015 7:22:52 AM
Anthera Pharmaceuticals, Inc. (ANTH) Announces Proposed Public Offering Of Common Stock 3/18/2015 6:35:20 AM
Anthera Pharmaceuticals, Inc. (ANTH) Reports 2014 Fourth Quarter And Fiscal Year Financial Results, Operational Update And Recent Event Highlights 3/16/2015 9:49:57 AM
Anthera Pharmaceuticals, Inc. (ANTH) Announces Completion Of Interim Analysis From Phase 3 Trial With Blisibimod For IgA Nephropathy 3/16/2015 7:27:02 AM
Anthera Pharmaceuticals, Inc. (ANTH) To Present At Cowen and Company Healthcare Conference 2/19/2015 11:55:57 AM
Anthera Pharmaceuticals, Inc. (ANTH) Regains Compliance With Nasdaq Listing Requirements 2/11/2015 7:49:04 AM
Anthera Pharmaceuticals, Inc. (ANTH) Announces Completion Of Interim Analysis From Phase 3 Trial With Blisibimod For Systemic Lupus Erythematosus 2/10/2015 7:19:09 AM
Anthera Pharmaceuticals, Inc. (ANTH) Announces Appointment Of Klara A. Dickinson As Senior Vice President, Chief Regulatory Officer 1/8/2015 8:52:50 AM
Anthera Pharmaceuticals, Inc. (ANTH) Announces Lupus Symposium During 2015 JP Morgan Healthcare Conference 12/31/2014 7:00:36 AM
12345678910...